[Effect of dalargin on morphologic and functional indices in experimental myocardial infarct].
D000818:Animals; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D004743:Enkephalin, Leucine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016308:Enkephalin, Leucine-2-Alanine / Q000031:analogs & derivatives*; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000503:physiopathology; D005996:Nitroglycerin / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D051381:Rats
D004743:Enkephalin, Leucine; D016308:Enkephalin, Leucine-2-Alanine; D011433:Propranolol; D005996:Nitroglycerin; C040996:enkephalin-Leu, Ala(2)-Arg(6)-
Vliianie dalargina na morfologicheskie i funktsional'nye pokazateli pri éksperimental'nom infarkte miokarda.